Results of a Swedish retrospective cohort study showed reduced rates of type 1 diabetes-related amputations over the past 2 decades.
In recent years, Sweden has seen a sharp decline in incidence of lower-level extremity amputations among individuals with type 1 diabetes (T1D), according to results of an observational cohort study. Findings were published in Diabetologia.
Because diabetes-related foot ulcers are common and healing is often delayed, limb loss through amputation “is not an infrequent final outcome,” the authors explained.
In addition, “about half of all nontraumatic amputations in the western world are attributable to diabetes, and an earlier study showed a 40-fold excess risk of amputations in people with T1D compared with the general population,” they said.
As the risk of lower extremity amputation (LEA) has been mostly studied in populations with type 2 diabetes, the investigators sought to better understand incidence over time and potential risk factors for LEA in patients with T1D.
All study participants were over the age of 18, had T1D, and were listed in the Swedish National Diabetes Register. Cohort data were then linked with several other national health registries to glean information on additional factors.
A total of 46,088 individuals with T1D (45% female) were included in final analyses, with a mean (SD) age of 32.5 (14.5) years. The mean duration of diabetes was 17.2 (14.5) years, and around 14% were smokers. Of the patients included, 1519 (3.3%) underwent amputation over a median follow-up of 12.4 years.
The researchers found:
Overall, “the risk of LEA was substantially reduced over time and the incidence was more than 40% lower during 2017-2019 than during 1998-2001,” the researchers wrote.
“The major reduction occurred during 2014-2019 along with clear improvements in glycemic control and renal function, which were the most prominent risk factors related to LEA.”
Data did not find a statistically significant association between increased low-density lipoprotein cholesterol concentrations and risk of amputation, while increased high-density lipoprotein levels offered a protective effect.
Improvements in amputation rates could be related to an increased focus on risk factor management, advanced treatments to optimize glycemic control, and additional measures used in multidisciplinary diabetes foot clinics, the authors hypothesized.
LEA can lead to reduced quality of life, influences work possibilities for many patients, and has significant short- and long-term impacts on health care costs.
Calling the improved prognosis for amputations, renal complications, and glycemic control over time a “breakthrough in T1D care,” the authors concluded, “our study indicates a shift in the era of diabetes probably due to the more extensive use of modern equipment in glucose-lowering therapy, such as advanced insulin pumps and continuous glucose monitoring devices.”
A lack of data on limb-specific risk factors such as neuropathy or deformities that affect amputation risk marks a limitation to this study. Causal relationships also cannot be drawn.
Reference:
Hallström S, Svensson A, Pivodic A, et al. Risk factors and incidence over time for lower extremity amputations in people with type 1 diabetes: an observational cohort study of 46, 088 patients from the Swedish national diabetes registry. Diabetologia. Published online September 8, 2021. doi:10.1007/s00125-021-05550-z
Study Shows Higher Infection Risk in Patients With T1D in Primary, Secondary Care
November 22nd 2023Researchers concluded there is a clinically important increase in infection risk among patients with T1D in both primary care and hospital settings, and that guidelines must be developed to reflect this risk and encourage earlier treatment.
Read More
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
High BMI Associated With Increased Risk of Type 1 Diabetes
November 10th 2023In a systematic and meta-analysis review of cohort studies that featured nearly 1.7 million individuals, study authors concluded that there is an association between high body mass index (BMI) and an increased risk of incident type 1 diabetes.
Read More
Glucose Fluctuation Linked to Slowed Nerve Conduction Velocity in Youth With T1D
November 2nd 2023High glucose variability in children and young adults with type 1 diabetes (T1D) strongly predicted slowed nerve conduction velocity, a forerunner of diabetic peripheral neuropathy, in a recent study.
Read More
Study Shows Higher Infection Risk in Patients With T1D in Primary, Secondary Care
November 22nd 2023Researchers concluded there is a clinically important increase in infection risk among patients with T1D in both primary care and hospital settings, and that guidelines must be developed to reflect this risk and encourage earlier treatment.
Read More
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
High BMI Associated With Increased Risk of Type 1 Diabetes
November 10th 2023In a systematic and meta-analysis review of cohort studies that featured nearly 1.7 million individuals, study authors concluded that there is an association between high body mass index (BMI) and an increased risk of incident type 1 diabetes.
Read More
Glucose Fluctuation Linked to Slowed Nerve Conduction Velocity in Youth With T1D
November 2nd 2023High glucose variability in children and young adults with type 1 diabetes (T1D) strongly predicted slowed nerve conduction velocity, a forerunner of diabetic peripheral neuropathy, in a recent study.
Read More
2 Clarke Drive
Cranbury, NJ 08512